✦ LIBER ✦

Individualised chemotherapy for non-small cell lung cancer (NSCLC): Nine months' experience in the North of England Cancer Network (NECN)

✍ Scribed by Jones, C.; Davis, J.; Gardiner, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of erlotinib in the management o

✍ Azribi, F.; Razak, A.R. Abdul; Gokul, S.; Singhal, S.; Hughes, A.N.; Gardiner, J 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 58 KB

34 Adjuvant chemotherapy for resected no

✍ Slater, S.; Nowicki, S.; Brown, J.; Steele, N. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 43 KB

25 Gefitinib in the treatment of non-sma

✍ Nugent, L.; Das, T.; Mohanamurali, J.; Danson, S.J.; Fisher, P.M.; Hatton, M.Q.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Milestones in the use of chemotherapy fo

✍ Jean Klastersky; Ahmad Awada 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 159 KB

43 Use of first line maintenance chemoth

✍ Stansfield, R.; Mohanamurali, J.; Danson, S.J.; Fisher, P.M.; Hatton, M.Q.; Lee, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Evaluation of the optimal duration of ch

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 272 KB